SEATTLE, Sept. 25, 2025 /PRNewswire/ -- YouthBio Therapeutics, a biotechnology company pioneering partial cellular reprogramming to treat diseases of aging, today announced a successful INTERACT ...

BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

In December 2023, company representatives met with FDA officials to discuss their plans to use partial cellular reprogramming in the eyes of people with optic nerve strokes, Rosenzweig-Lipson said.

These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear restoration of methylation patterns with functional enrichment of neuronal ...

In 2006, Kyoto University’s Professor Yamanaka Shin’ya made a groundbreaking discovery: a method to reprogram ordinary body cells such as skin, nerve, or bone cells into a highly adaptable, ...

A startup cofounded by a renowned Harvard geneticist has taken a step toward cracking the human body’s biological breakdown by securing FDA approval to test its cutting-edge gene therapy on humans.

Aging has long been seen as a natural, unstoppable part of life. From the moment we're born, our bodies transform — first through growth, then through gradual decline. Over time, stamina wanes, ...

A report that "aging" can be "reversed" by reprogramming genes was published in the academic journal "Cell" dated 15th December 2016. Actually, I succeeded in life prolongation by 30% in the mouse.

ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...